New Symmetrically Esterified m-Bromobenzyl Non-Aminobisphosphonates Inhibited Breast Cancer Growth and Metastases

Mohamed Abdelkarim, Erwann Guenin, Odile Sainte-Catherine et al. · 2009

Read New Symmetrically Esterified m-Bromobenzyl Non-Aminobisphosphonates Inhibited Breast Cancer Growth and Metastases by Mohamed Abdelkarim, Erwann Guenin, Odile Sainte-Catherine et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004685.txt.

Description

Mohamed Abdelkarim and colleagues made new forms of a bone drug that may fight breast cancer, for PLOS ONE in 2009. Drugs called bisphosphonates show promise in cancer care. Their flaw is that they stick to bone and reach soft tissue poorly, which limits their use in breast tumors.

The team masked parts of the drug to help it slip into soft tissue. They then tested the new forms on breast cancer growth and spread. Better reach could turn a bone drug into a wider cancer tool. The work is an early step that still needs much more testing.

Catalog record

CREATORMohamed Abdelkarim, Erwann Guenin, Odile Sainte-Catherine et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004685

Browse the full library · About the Tower of Babel